Closed
SectorHealthcare
160.19 1.32
24h
Min
154.97
Max
160.4
Income | 61M -38M |
---|---|
Sales | 116M 174M |
EPS | -0.64 |
Profit margin | -22.119 |
Employees | 1,017 |
EBITDA | 33M -38M |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +31.85% upside |
Next Earnings | 1 maj 2025 |
---|
Market Cap | 9.9B |
---|---|
Previous open | 158.87 |
Previous close | 160.19 |
By Trading Central
Confidence
Weak Bullish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 208.5 USD 31.85%
High 289 USD
Low 162 USD
Based on 13 Wall Street analysts offering 12 month price targets forAscendis Pharma A-S ADR - Dist in the last 3 months.
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$